Sign up for an openevidence medical AI account using your email address
Content: text (0 symbol)
Available: 1
Uploaded:
Positive responses: 0
Negative responses: 0
Sold: 0
Refunds: 0
$26.3
I will create an OpenEvidence account using your email address. You will receive a full account with the Deep Thinking feature, with no expiration date.
Please note! We will need to coordinate a time, as I will need the registration confirmation code from your email. Also, to use the account, you will need a proxy or another way to change your location to the United States.
OpenEvidence is a medical AI service for doctors, not a “regular” chatbot like ChatGPT.## What is it? OpenEvidence is an American company that makes a medical search engine and chatbot for clinical decisions. Key points:* Focused solely on medicine and only for healthcare professionals and students. It answers doctors´ questions based strictly on peer-reviewed literature (NEJM, JAMA, etc.) and always provides links to sources.
* It is currently positioned as one of the leading AI-supported clinical decision-making platforms in the US (according to their data, more than 40% of American doctors are registered and use the service daily). Key features: Essentially, it is a “search engine + AI assistant” for doctors:* Answers to clinical questions in natural language, with citations to specific studies. * Support for clinical decisions: diagnosis, choice of therapy, dosages, comparison of treatment regimens, etc. * New features (OpenEvidence 2.0): * texts for insurance companies (prior auth letters),
* calculation of scores, * memos and instructions for patients, * document upload and analysis.* DeepConsult — “research agents” that can comb through the literature in the background and form a consensus-style conclusion on a complex case. ## Technological “feature”* The company announced that their model scored 100% on the USMLE (American licensing exam for doctors) — a first in the history of AI systems. * The models are trained specifically on medical literature and are focused on explainability and traceability.
Please note! We will need to coordinate a time, as I will need the registration confirmation code from your email. Also, to use the account, you will need a proxy or another way to change your location to the United States.
OpenEvidence is a medical AI service for doctors, not a “regular” chatbot like ChatGPT.## What is it? OpenEvidence is an American company that makes a medical search engine and chatbot for clinical decisions. Key points:* Focused solely on medicine and only for healthcare professionals and students. It answers doctors´ questions based strictly on peer-reviewed literature (NEJM, JAMA, etc.) and always provides links to sources.
* It is currently positioned as one of the leading AI-supported clinical decision-making platforms in the US (according to their data, more than 40% of American doctors are registered and use the service daily). Key features: Essentially, it is a “search engine + AI assistant” for doctors:* Answers to clinical questions in natural language, with citations to specific studies. * Support for clinical decisions: diagnosis, choice of therapy, dosages, comparison of treatment regimens, etc. * New features (OpenEvidence 2.0): * texts for insurance companies (prior auth letters),
* calculation of scores, * memos and instructions for patients, * document upload and analysis.* DeepConsult — “research agents” that can comb through the literature in the background and form a consensus-style conclusion on a complex case. ## Technological “feature”* The company announced that their model scored 100% on the USMLE (American licensing exam for doctors) — a first in the history of AI systems. * The models are trained specifically on medical literature and are focused on explainability and traceability.
After making the purchase, please send me the payment confirmation code, along with your email address and the times when you’re online. We need to coordinate a time when you’re online, since I’ll need the code from your email to register the account.
No feedback yet